PMPaulina Malon

Paulina Malon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paulina Malon has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acquired retinal toxicity following ocular surgery and pharmacotherapy: mechanisms and clinical implications

    by Paulina Malon, Anna Bych, Szymon Konczyński, Karolina Kaźmierczak

    Acquired retinal toxicity represents an important and potentially vision-threatening complication of medical therapies, surgical procedures and environmental exposures. It may result from phototoxic injury, intraocular dyes, intravitreal medications or long-term systemic drug use. Advances in retinal imaging have improved early detection. However, retinal damage is often irreversible once established. Understanding the mechanisms, risk factors, and clinical manifestations of retinal toxicity is essential for prevention, timely diagnosis and optimal patient management. This review summarizes the main mechanisms of acquired retinal toxicity, illustrates them with representative clinical cases and discusses current strategies for prevention and management.

  • Open Access

    VITAMIN D DEFICIENCY AND RISK OF OVERUSE MUSCULOSKELETAL INJURIES IN RECREATIONAL RUNNERS

    by Nel Geworkian, Paulina Malon, Aleksandra Trojańska, Anita Pieńkowska, Karol Śliwa, Natalia Hariasz, Martyna Pietz, Anita Szymańska

    Recreational distance running provides substantial cardiovascular and metabolic benefits but is associated with a high burden of overuse musculoskeletal injuries, particularly bone stress injuries and medial tibial stress syndrome. Low vitamin D status is common in athletes, including endurance runners living at higher latitudes, and may adversely affect bone, muscle and tendon adaptation to repetitive loading. This narrative review synthesises current evidence on vitamin D metabolism, its roles in the musculoskeletal system and the relationship between serum 25-hydroxyvitamin D [25(OH)D] and overuse injuries in recreational and sub-elite runners. Electronic databases were searched for observational, interventional and review studies addressing vitamin D status, bone stress injuries, soft-tissue overuse conditions and determinants of 25(OH)D in endurance athletes, with particular emphasis on running cohorts and military populations exposed to similar mechanical loads. Observational and interventional data in military recruits and athletes show that low 25(OH)D status is consistently associated with a higher risk of bone stress injuries, whereas evidence for muscle strains, tendinopathies and non-specific musculoskeletal pain remains limited and heterogeneous. Studies in endurance athletes indicate that vitamin D insufficiency is frequent, especially during winter, at higher latitudes and in those training predominantly indoors or outside peak sunlight hours. However, few prospective studies have specifically examined recreational runners, and virtually no trials have tested whether correcting vitamin D insufficiency reduces overuse injury incidence beyond standard load management and nutritional strategies. Available evidence supports viewing vitamin D as one modifiable systemic factor within multifactorial overuse injury prevention in runners, rather than an isolated causal agent. Maintaining serum 25(OH)D at least above 50 nmol/L, and possibly around 75–100 nmol/L in runners at elevated risk of bone stress injuries, appears reasonable, particularly in those with limited sun exposure or features of relative energy deficiency. Well-designed prospective cohorts and randomized trials in recreational runners are needed to clarify causal effects and refine screening and supplementation recommendations.

  • Open Access

    HEALTH PROPERTIES AND THERAPEUTIC POTENTIAL OF YERBA MATE (ILEX PARAGUARIENSIS) IN HEALTHCARE: A COMPREHENSIVE REVIEW

    by Aleksandra Trojańska, Karol Śliwa, Anita Pieńkowska, Paulina Malon, Nel Geworkian, Natalia Hariasz, Martyna Pietz, Anita Szymańska

    Yerba mate (Ilex paraguariensis) has emerged as a promising nutraceutical with pleiotropic metabolic and immunomodulatory effects relevant to cardiovascular risk modification, obesity care, glycemic control, oxidative stress, gut immune homeostasis, and inflammatory bowel disease. Randomized clinical data demonstrate reductions in body fat mass, percent body fat, and waist–hip ratio without safety concerns after 12 weeks of standardized supplementation, aligning with mechanistic rodent work showing tissuespecific bioenergetic reprogramming, antiinflammatory signaling, improved mitochondrial coupling in muscle, adipose thermogenic uncoupling, and enhanced hepatic redox tone. Metaanalytic evidence on lipids remains inconclusive overall, though individual trials report favorable LDLC signals in dyslipidemia, including addon effects to statins. Preclinical and translational studies indicate attenuation of hypothalamic and adipose inflammation, improved insulin signaling via PI3K–AKT pathways, modulation of macrophage polarization toward M2 phenotypes, and microbiota shifts that may augment metabolic and intestinal antiinflammatory activity. Safety signals are generally favorable when consumed in moderate amounts, with attention to preparation practices to minimize polycyclic aromatic hydrocarbons and to manganese intake with very high volume use. This narrative synthesizes clinically salient evidence and proposes patient-oriented use of yerba mate in cardiometabolic risk reduction, weight management, and adjunctive care in colitis, while outlining dosing, formulation, and monitoring considerations and research priorities.

  • Open Access

    GLP 1 RECEPTOR AGONISTS AND THEIR EFFECTS ON REWARD AND COMPULSIVE BEHAVIORS

    by Anita Pieńkowska, Paulina Malon, Karol Śliwa, Aleksandra Trojańska, Nel Geworkian, Natalia Hariasz, Martyna Pietz, Anita Szymańska

    Background: Addiction and compulsive behaviors are widespread challenges that affect both individual and societal well-being. These behaviors involve persistent engagement in rewarding stimuli despite negative consequences. Glucagon-like peptide-1 (GLP‑1) receptor agonists, initially developed for metabolic disorders, have been shown to modulate neural circuits involved in reward, motivation, and compulsive behavior. Methods: To explore these questions, this review synthesizes evidence from animal studies, mechanistic neurobiological research, neuroimaging, and emerging human trials. The focus is on the effects of GLP‑1 receptor activation on reward processing, motivation, and compulsive behaviors. Results: Preclinical studies indicate that GLP‑1 receptor agonists reduce drug- and food-related reward seeking, suppress relapse-like behavior, and modulate phasic dopamine signaling in mesolimbic circuits. Neurochemical and electrophysiological studies demonstrate coordinated activity between dopaminergic and inhibitory neurons. In humans, early trials suggest GLP‑1 receptor agonists can reduce alcohol consumption and craving, and observational data hint at broader effects on other reward-related behaviors. Conclusion: GLP‑1 receptor signaling modulates central motivation and reduces maladaptive reward-seeking. These findings suggest GLP‑1 receptor agonists have therapeutic potential for compulsive behaviors and addiction, relevant to behavioral science, psychiatry, and public health.

  • Open Access

    THE IMPACT OF BOTULINUM TOXIN ON VOICE QUALITY AFTER LARYNGECTOMY

    by Natalia Hariasz, Paulina Malon, Karol Śliwa, Anita Pieńkowska, Aleksandra Trojańska, Nel Geworkian, Martyna Pietz, Anita Szymańska

    Objectives: Tracheoesophageal (TE) speech is the preferred method of voice rehabilitation after total laryngectomy; however, its effectiveness is frequently compromised by pharyngoesophageal spasm (PES). The objective of this review was to evaluate the anatomical, physiological, diagnostic, and therapeutic evidence supporting the use of botulinum toxin (BTX) for the management of PES-related TE voice dysfunction. Methods: A narrative review of peer-reviewed English-language literature was conducted using PubMed and major scientific databases. Studies addressing pharyngoesophageal segment physiology, diagnostic assessment of PES, and clinical, acoustic, aerodynamic, and perceptual outcomes following BTX injection in laryngectomized patients were qualitatively synthesized. Results: Across heterogeneous study designs, PES was consistently identified as a primary barrier to effective TE phonation, characterized by elevated intraluminal pressure, restricted segmental aperture, and impaired vibratory behavior. BTX injection reliably reduced PE segment hypertonicity, resulting in improved airflow dynamics, enhanced vibratory regularity, increased maximum phonation time, and improved acoustic stability. Perceptual assessments and patient-reported outcomes demonstrated significant gains in speech intelligibility, vocal effort, communicative participation, and quality of life. Additional benefits included improved prosthesis function and longevity. Adverse effects were mild, transient, and infrequent. Conclusions: Botulinum toxin is a safe, minimally invasive, and physiologically targeted treatment for PES-related TE speech dysfunction. The convergent evidence supports its role as a first-line or adjunctive therapy for restoring voice quality and communication after total laryngectomy.

  • Open Access

    Dynapenia syndrome in geriatrics – clinical characteristics, distinction from sarcopenia, and contemporary therapeutic approaches

    by Paulina Malon, Karol Śliwa, Anita Pieńkowska, Aleksandra Trojańska, Nel Geworkian, Natalia Hariasz, Martyna Pietz, Anita Szymańska

    Introduction Dynapenia is an age-related loss of muscle strength despite preserved muscle mass, leading to functional decline, loss of independence, falls, and higher mortality. Its development is influenced by neuromuscular, endocrine, and metabolic changes, compounded by chronic inflammation, low activity, and inadequate nutrition. Results Resistance training is the most effective strategy to mitigate strength loss, enhancing neuromuscular function and physical performance. Aerobic exercise improves endurance and mobility. Adequate protein intake (1.0–1.2 g/kg) and supplementation with vitamin D, creatine, leucine, and omega-3 fatty acids support training adaptations. Early detection via handgrip strength allows timely interventions. Discussion Combining targeted exercise with optimal nutrition and supplementation maintains strength and independence in older adults. Interventions should be individualized based on health and functional status. Emerging molecular and gene-based therapies are experimental but may complement lifestyle approaches. Conclusion Dynapenia is not inevitable with aging. Early recognition, regular training, and proper nutrition can slow strength loss, reduce fall risk, and improve well-being. Materials and methods A review of scientific articles from PubMed, Google Scholar, and Dove Press Medical focused on dynapenia, muscle aging, and physical and nutritional interventions in older adults.

  • Open Access

    Falls in the Elderly: Determinants, Consequences and Prevention Approaches

    by Paulina Halik, Justyna Jusiak, Lidia Wydeheft, Paulina Malon, Jakub Lewiński, Kornelia Kędziora-Kornatowska

    Introduction:Falls among older adults are a major global public health problem and a leading cause of injury, disability and mortality in individuals aged 65 years and older. With population aging, the incidence and burden of falls are expected to increase. Falls result from complex interactions between intrinsic age-related changes and extrinsic environmental factors, making them a core geriatric syndrome requiring comprehensive management.Aim:This review aimed to summarize current evidence on the epidemiology, determinants, consequences, and prevention strategies for falls in older adults.Materials and Methods:A narrative review was conducted using PubMed, Scopus, and Web of Science databases. Peer-reviewed articles, meta-analyses, and clinical guidelines published between 2018 and 2025 were included.Results:Approximately one-third of community-dwelling adults aged ≥65 experience at least one fall annually, with higher rates among those aged ≥80 and residents of long-term care facilities. Major risk factors include advanced age, prior falls, gait and balance impairment, muscle weakness, frailty, multimorbidity, polypharmacy, visual and cognitive impairment, and environmental hazards. Falls often lead to fractures, head injuries, functional decline, psychological consequences such as fear of falling, and increased healthcare utilization. Discussion:The findings confirm the multifactorial nature of falls and the cumulative impact of modifiable and non-modifiable risk factors. Psychological consequences, particularly fear of falling, contribute to recurrent falls and progressive functional decline. Conclusions:Falls in older adults represent a complex geriatric syndrome with substantial clinical and socioeconomic consequences. Integrated, multifactorial prevention programs based on comprehensive geriatric assessment are essential to reduce fall risk, maintain independence, and mitigate healthcare system burden.


  • Open Access

    GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients

    by Lidia Wydeheft, Justyna Jusiak, Paulina Halik, Paulina Malon, Kornelia Kędziora-Kornatowska

    Introduction. The global prevalence of obesity has increased markedly in recent decades, becoming a major contributor to metabolic syndrome (MetS), cardiovascular disease, and mortality. This trend increasingly affects older adults, in whom obesity often coexists with sarcopenia, frailty, and multimorbidity. Novel pharmacological therapies, particularly glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, have demonstrated unprecedented efficacy in weight reduction, yet data in geriatric populations remain limited. Materials and Methods. A systematic literature search of PubMed, Embase, and Scopus was conducted for studies published between 2020 and 2025. Results. Both semaglutide and tirzepatide produced substantial and sustained weight loss, with mean reductions ranging from approximately 15% to over 20%, and significant improvements in glycemic control, lipid profile, and blood pressure. Tirzepatide consistently achieved greater weight reduction than semaglutide. Limited subgroup and post hoc analyses suggest that older adults experience meaningful metabolic benefits, although higher rates of gastrointestinal adverse events and treatment discontinuation have been reported. Discussion. In older patients, pharmacologically induced weight loss may be accompanied by disproportionate loss of lean body mass, increasing the risk of sarcopenia, frailty, and functional decline. Without appropriate nutritional and exercise interventions, these risks may attenuate the cardiometabolic benefits of treatment. Conclusions. GLP-1 and dual GLP-1/GIP receptor agonists are highly effective therapies for obesity, including in older adults, but require individualized risk–benefit assessment. Integration with nutritional support and resistance training is essential.

  • Open Access

    Ocular manifestations in Hashimoto’s thyroiditis and Graves’ disease

    by Paulina Malon, Szymon Konczyński, Anna Bych, Karolina Kaźmierczak

    Introduction: Autoimmune thyroid diseases such as Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) can present with ocular manifestations. While these are well documented in GD, less is known about their prevalence and characteristics in HT.Methods: This narrative review summarizes current knowledge on the epidemiology, pathophysiology, clinical features, diagnostics, and treatment of ophthalmic symptoms in HT and GD. Special focus is placed on dry eye syndrome, thyroid-associated ophthalmopathy (TAO), and diagnostic approaches including imaging and tear biomarker analysis.Results: HT most frequently presents with dry eye syndrome, eyelid edema, and rare manifestations like diplopia or vision loss. TAO, typically associated with GD, is also observed in a small percentage of HT cases. GD-related orbitopathy affects up to 50% of patients and may lead to severe complications, including optic neuropathy. Several immunological markers, including TSHR and IGF-1R, play a key role in the pathogenesis of Graves’ orbitopathy (GO).Conclusion: Ocular symptoms in HT and GD are diverse and can significantly impact patients’ quality of life. Although GO is more characteristic of GD, its presence in HT should not be underestimated. Comprehensive ophthalmologic evaluation is essential for timely diagnosis and treatment.

  • Open Access

    Providing general anesthesia for elderly patients during planned procedures — main differences compared to younger adults

    by Lidia Wydeheft, Paulina Malon, Anna Bych, Paulina Halik, Justyna Jusiak, Dorota Ratajczak, Michał Janiak, Kornelia Kędziora-Kornatowska

    IntroductionThe aging population has increased the number of older adults undergoing elective surgery, making safe, individualized general anesthesia essential. Age-related physiological changes—such as reduced cardiac, pulmonary, hepatic, and renal reserve, multimorbidity, frailty, and altered body composition—affect drug metabolism, pharmacodynamics, and tolerance to perioperative stress, resulting in higher rates of cardiovascular, respiratory, and cognitive complications compared with younger adults.ResultsOlder patients require careful dose adjustments due to reduced drug clearance and increased sensitivity to anesthetics. Propofol-based total intravenous anesthesia (TIVA), EEG-guided depth monitoring, and agents like etomidate or dexmedetomidine improve hemodynamic stability and reduce postoperative cognitive dysfunction (POCD) and delirium. Comprehensive preoperative evaluation—including frailty screening, cognitive and functional assessment, and medication review—helps identify high-risk patients. Postoperative vigilance is needed to manage respiratory depression, inadequate pain control, and prolonged recovery. Telemedicine has proven effective for pre-anesthetic assessment, enabling early detection of cognitive impairment and reducing time, cost, and travel burden.DiscussionPersonalized anesthesia considering frailty, comorbidities, and altered drug metabolism improves safety. Minimizing anesthetic duration, selecting safer agents, EEG guidance, and TIVA support better outcomes, while telemedicine enhances patient-centered care.ConclusionGeneral anesthesia in older adults requires tailored strategies addressing age-related changes and increased perioperative vulnerability. Individualized dosing, careful agent selection, structured preoperative assessment, postoperative monitoring, and telemedicine support can enhance safety and outcomes, highlighting key differences from younger patients and emphasizing a holistic, evidence-based perioperative approach.